Fresenius Medical Care AG & Co KGaA
XETRA:FME
Wall Street
Price Targets
FME Price Targets Summary
Fresenius Medical Care AG & Co KGaA
According to Wall Street analysts, the average 1-year price target for FME is 39.81 EUR with a low forecast of 26.26 EUR and a high forecast of 52.5 EUR.
Operating Income
Forecast
Operating Income Estimate
Fresenius Medical Care AG & Co KGaA
For the last 8 years the compound annual growth rate for Fresenius Medical Care AG & Co KGaA's operating income is -6%. The projected CAGR for the next 3 years is 23%.
Net Income
Forecast
Net Income Estimate
Fresenius Medical Care AG & Co KGaA
For the last 8 years the compound annual growth rate for Fresenius Medical Care AG & Co KGaA's net income is -8%. The projected CAGR for the next 3 years is 34%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FME's stock price target?
Price Target
39.81
EUR
According to Wall Street analysts, the average 1-year price target for FME is 39.81 EUR with a low forecast of 26.26 EUR and a high forecast of 52.5 EUR.
What is Fresenius Medical Care AG & Co KGaA's Revenue forecast?
Projected CAGR
4%
For the last 8 years the compound annual growth rate for Fresenius Medical Care AG & Co KGaA's revenue is 3%. The projected CAGR for the next 3 years is 4%.
What is Fresenius Medical Care AG & Co KGaA's Operating Income forecast?
Projected CAGR
23%
For the last 8 years the compound annual growth rate for Fresenius Medical Care AG & Co KGaA's operating income is -6%. The projected CAGR for the next 3 years is 23%.
What is Fresenius Medical Care AG & Co KGaA's Net Income forecast?
Projected CAGR
34%
For the last 8 years the compound annual growth rate for Fresenius Medical Care AG & Co KGaA's net income is -8%. The projected CAGR for the next 3 years is 34%.